Verastem (VSTM) Assets Growth (5y) (2016 - 2026)

Verastem (VSTM) Assets Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.72%
Dec 31, 2025 9.81%
Sep 30, 2025 -4.08%
Jun 30, 2025 -0.23%
Mar 31, 2025 -8.75%
Dec 31, 2024 -6.88%
Sep 30, 2024 -8.08%
Jun 30, 2024 -13.51%
Mar 31, 2024 -12.68%
Dec 31, 2023 -11.59%
Sep 30, 2023 -0.78%
Jun 30, 2023 2.09%
Mar 31, 2023 12.06%
Dec 31, 2022 1.14%
Sep 30, 2022 11.96%
Jun 30, 2022 10.18%
Mar 31, 2022 8.78%
Dec 31, 2021 5.38%
Sep 30, 2021 4.67%
Jun 30, 2021 5.36%